Gulf Pharmaceutical Industries P.S.C.

ADX:JULPHAR Stock Report

Market Cap: د.إ1.1b

Gulf Pharmaceutical Industries P.S.C Ownership

Who are the major shareholders and have insiders been buying or selling?


Recent Insider Transactions

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

What is the ownership structure of JULPHAR?
Owner TypeNumber of SharesOwnership Percentage
Institutions1,760,2790.152%
State or Government141,399,88412.2%
Individual Insiders274,441,69523.8%
General Public353,577,39830.6%
Private Companies384,048,55533.2%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.


Top Shareholders

Top 7 shareholders own 69.39% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
24.1%
Middle East Pharma For Investments
278,334,813د.إ268.3m0%no data
12.2%
Ras Al Khaimah (Emirate of)
141,399,884د.إ136.3m0%no data
9.15%
Arab Company for Drug Industries & Medical Supplies
105,713,742د.إ101.9m0%no data
9%
Yasser Youssef Naghi
103,970,503د.إ100.2m0%no data
7.58%
Mohammed Abdulaziz Rabie Al Muhairi
87,552,405د.إ84.4m0%no data
7.18%
Faisal Bin Saqr Bin Al Qassimi
82,918,787د.إ79.9m0%no data
0.15%
Dimensional Fund Advisors LP
1,760,279د.إ1.7m6.1%no data
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.